Fig. 3From: Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancerCytotoxic activity of expanded NK cells against K-562 cells. 4 h cytotoxicity from 14 patients against K-562 target cells. Mean cell death in each patient at the indicated E:T ratios in triplicate culturesBack to article page